Phase
Condition
Thromboembolism
Treatment
Survey
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients referred with CTED and/or CTEPH defined as:
Mean pulmonary arterial pressure (mPAP) > 20 mmHg at rest with pulmonaryvascular resistance (PVR) > 2 Wood units (WU); or if mPAP ≤ 20 mmHg or PVR ≤ 2WU at rest, have exercise limitations from chronic thromboembolic pulmonarydisease (CTEPD) without pulmonary hypertension (PH)
Radiologic finding of chronic thromboembolic disease, including abnormalventilation perfusion scan, pulmonary angiogram, computer tomographic pulmonaryangiogram, or magnetic resonance pulmonary angiogram
Post-embolic exercise intolerance and evidence of chronic thromboembolicdisease in the absence of resting pulmonary hypertension
Treatment with anticoagulation for ≥ 3 months before diagnosis of CTEPH or CTEPDwithout PH
Age ≥ 18 years
Exclusion
Exclusion Criteria:
Main cause of PH other than World Health Organization (WHO) group 4 (CTEPH)
Patient's refusal to participate in clinical research and/or receive intervention
Study Design
Connect with a study center
University of California San Francisco
San Francisco, California 94143
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.